SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
406A Randomized Controlled Trial of a Humanized á4â7 Antibody in UlceratiIcebrg-5/15/2003
405Isotechnika Earns C$21.9M Drug Devt Milestone Payment Thursday May 15, 12:58 pm Icebrg-5/15/2003
404Genmab Completes Initial Accrual in Humax-CD4 Phase IIb Psoriasis Study. ThursdaIcebrg-5/15/2003
403Genentech and XOMA Discontinue Rheumatoid Arthritis Trial SOUTH SAN FRANCISCO &nigel bates-5/12/2003
402Roche psoriasis drug to include depression warning Thu May 08, 2003 03:28 PM ET sim1-5/10/2003
401Inflammation: Promise for glycolysis inhibitor HIF1 inhibitors are being develoJohn McCarthy-5/3/2003
400CellGate Announces Phase IIa Study Results of PsorBan(R) In the Treatment of PsoJohn McCarthy-5/2/2003
399Blood 2003 Mar 20; [epub ahead of print] Related Articles, Links Transgenic keokalani'nui-4/27/2003
398Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritkeokalani'nui-4/21/2003
397from the PDLI 10-K, filed about three weeks ago..... <i>We have also deciscaram(o)uche-4/19/2003
396Nature Reviews Immunology 3, 262 (2003) CYTOKINES Common-chain confusion Elascaram(o)uche-4/19/2003
395There's a post around here somewhere, maybe in the VDXX thread?? Ironic, anscaram(o)uche-4/4/2003
394From a SSB report on Biogen Message 18795913 <pre> <i>* Clinical rIcebrg-4/4/2003
393CAMPATH Clinical Data in Multiple Sclerosis Presented at American Academy of NeuIcebrg-4/2/2003
392GS on recent Psoriasis Meeting: Message 18749292Icebrg-3/25/2003
391Four Clinical Trials Presented at AAD Show Ligand's Targretin, Panretin DemoIcebrg-3/25/2003
390Competition expected for new, improved psoriasis drugs Bernadette Tansey, sim1-3/25/2003
389Market for Psoriasis Drugs Could Top $1 Billion New medications may be asim1-3/25/2003
388Psoriasis treatment shows promise RAPTIVA EASES PAIN, SAY GENENTECH AND XOMA sim1-3/23/2003
387[ anti-CD11a/DNA and XOMA/long-term open label study ] Preliminary Results fromscaram(o)uche-3/22/2003
386biz.yahoo.comArthur Radley-3/21/2003
385Phase III Study Results with Raptiva in the Treatment of Psoriasis Presented at Icebrg-3/21/2003
384[RA biomarker -- myeloid-related protein 8] >>J Proteome Res 2002 Nov-Dectuck-3/21/2003
383J&J arthritis drug combats psoriasis in study Friday March 21, 10:31 am ET keokalani'nui-3/21/2003
382Positive Results From ENBREL Psoriasis Study to be Presented by RWJMS ResearcherArthur Radley-3/21/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News